Medical Distributors Applaud Inclusion Of Healthcare Priorities In Omnibus Legislation
Alexandria, VA, Dec. 20, 2022 – The Health Industry Distributors Association (HIDA) today applauded the inclusion of provisions to strengthen pandemic preparedness and preserve lab services in the text of the omnibus appropriations act released by Congress.
“These provisions are a victory for patients and providers,” said HIDA President and CEO Matthew J. Rowan. “They are the culmination of over a year’s worth of advocacy by HIDA and our members to strengthen the medical supply chain.”
The bipartisan provisions of the PREVENT Pandemics Act in the omnibus appropriations act will improve preparedness strategy and coordination while strengthening public-private partnerships. Specifically, the PREVENT Pandemics Act contains improvements to the healthcare supply chain, providing the Strategic National Stockpile with additional flexibility to partner with distributors and manufacturers.
The omnibus appropriations act also includes a revised phase-in of Medicare clinical laboratory test payment changes, which would postpone by one year cuts of up to 15 percent that are scheduled to go into effect for many common laboratory diagnostic services.
HIDA urged the inclusion of these provisions in a letter to Congressional leadership released on December 8. HIDA and its members engaged with policy makers throughout the year. Highlights of industry leadership include:
Health Industry Distributors Association (HIDA) represents the healthcare distribution network – the essential link between global healthcare supply manufacturers and local care providers. HIDA members operate more than 500+ distribution centers to bring critical products, supplies, and services to more than 560,000 healthcare settings across the U.S., including hospitals, long-term care, physician practices, home care, and laboratories. Visit HIDA.org.